ML20196G233
| ML20196G233 | |
| Person / Time | |
|---|---|
| Issue date: | 05/09/1997 |
| From: | Seale R Advisory Committee on Reactor Safeguards |
| To: | Shirley Ann Jackson, The Chairman NRC COMMISSION (OCM) |
| References | |
| ACRS-R-1699, NUDOCS 9705150329 | |
| Download: ML20196G233 (4) | |
Text
_ -_
i.
e arg#c,,
UNITED STATES ACRSR-1699 8
NUCLEAR REGULATORY COMMISSION i
n PDR L
,E ADVISORY COMMITTEE ON REACTOR SAFEGUARDS j
i /
Y
'C WASHINGTON, D. C. 20555 I
4.,...../
May 9, 1997
)
t.
t 4
)
l The Honorable Shirley Ann Jackson
-Chairman i
U.S. Nuclear Regulatory Commission l
Washington, D.C.
20555-0001
Dear Chairman Jackson:
i
SUBJECT:
THE POLICY REGARDING STOCKPILING OF POTASSTUM IODIDE During the 441st meeting of the Advisory Committee on Reactor Safeguards, May 1-3, 1997, we completed our disemion of the bases for the NRC staff's denial of a petition for rulemaking relating to the reevaluation of the policy regarding the use of potasaium iodide (KI) af ter a severe accident at a nuclear. power plant.
During our 440th meeting,' April 3-4, 1997, we discussed this matter with representatives of the NRC staff, the Nuclear Energy Institute (NEI), and the State of Illinois.
We also had the benefit of the documents referenced.
Mr. Peter Crane, a member of the NRC staff in the Office of the General Counsel,. requesting a reevaluation of the Commission's
]
had previously filed a dif;'ering professional opinion in 1989 policy on KI.
Mr. Crane also filed a ' petition on September 9, 1995, as a private citizen requesting a rulemaPing to inplement the j
recommendations of the Kemeny Commission that the United States i
stockpile KI for protection of the thyroid following nuclear accidents.
Specifically, Mr. Crane requested that the commission amend its regulations (10 CFR 50. 47 (b) (10) ) to specify that the prophylactic use of KI for the general population within the plume exposure pathway Emergency Planning Zone (EPZ) for each licensed j
nuclear power plant be identified as one of the
" range of f
~
protective actions" required to be set forth in State and local O
There is no argument that KI can act as an effective radioiodine blocker if administered in a timely manner.
But in the supporting documentation and. presentations, the staff did not adequately address several technical concerns that have been expressed repeatedly when this issue has arisen in the past.
These include the spectrum of side effects that would be encountered in the
~
administration of KI to a large popub., tion or the identification of the timing of KI administration to ensure effective blocking of 9705150329 970509 Of 'N ~
M E
.)
_ ~.
I 2
radiciodine released during nuclear accidents.
We saw no meaningful study of KI predistribution, nor did we see any examination of limited KI shelf life.
conclusion We find the arguments for the stockpiling of KI to be unconvincing.
Therefore, we agree with the staff's position that a revision to the regulations is unwarranted and that the petition should be denied.
Discussion i
In
- 1996, the Federal Radiological Preparedness Coordinating Committee (FRPCC) had convened an ad hoc Subcommittee on Potassium Iodide to review the public use of KI following a nuclear accident.
Based on its evaluation of new information and comments from interested parties, the FRPCC Subcommittee concluded that "while the viewpoints presented at the public meeting were compelling, the 1996 Subcommittee heard no new information that seriously challenges the bases for the 1985 recommendation concerning public use of KI."
The 1985 policy did not recommend predistribution or stockpiling of KI for the general public.
Nonetheless, the FRPCC Subcommittee made several recommendations including the following:
Without changing the Federal policy, and without interceding in e
the State's prerogative to make its own decision on whether or not to use KI, the Federal Government (NRC, or through FEMA, etc.) should fund the purchase of a KI stockpile for any State that, hereafter, decides to incorporate its use as a protective measure for the general public.
Local jurisdictions, who have the option of incorporating the e
use of KI in their protective measures independent of the State's plan, consider, in consultation with the State, the use of KI as a possible protective measure, and be aware that if they choose to do so, they would then incur a responsibility to develop plans for distribution or predistribution of the KI.
The full FRPCC endorsed the Subcommittee's recommendations and plans to publish a revised Federal policy statement on the distribution of KI.
The staff's position is that a revision to the regulations as requested by the petitioner is unnecessary because the anticipated actions by the FRPCC will address substantially the fundamental concerns of the petitioner without incurring the burden of changing all State and local emergency plans.
The actions expected to be recommended by the FRPCC will ensure that, in contrast to the inadeque.:e supply situation which existed at the time of the Threa Mile Island accident, KI could be made available if needed.
m l
1 3
Representatives of NEI and the State of Illinois concurred with the staff's recommendation that the petition be denied and that the State and local governments be allowed to decide when to include KI' for general public use in emergency plans.
They argued that stockpiling or predistributing KI for the general public will not add any significant public health and safety benefit beyond that provided by existing emergency preparedness at commercial nuclear t
power plants.
l Additional comments by ACRS Member Dr.
T.
S.
Kress are presented below.
l-Sincerely, R. L.
Seale t
l Chairman i
l Additional Comments by ACRS Member Dr.
T.
S.
Kress l
I I disagree with the Committee's position on this issue.
It has j
been recognized for more than 40 years that KI would be an l
l effective prophylaxis against fission-product-iod*ne-induced thyroid cancer if taken on a timely basis before exposure.
In the 1
l face of this almost universally agreed upon knowledge, the long-l standing policy of NRC of leaving the decision up to the States as i
to whether or not to stockpile KI has resulted in only two States adopting the strategy.
It is obvious that the desired result of s'
having this remedy available if needed has not been achieved by this policy and most likely never will be.
i 8
The major difficulties with KI stockpiling are " limited rhelf life" and " difficulty of distribution" (or whether or not to pre-distribute).
The issue of limited shelf life essentially has been I
l resolved by new encapsulation technology.
The distrjoution issue just needs a real resolve on the part of NRC to address it.
There are a number of workable solutions.
The oft-cited failed initial attempt-in Tennessee to predistribute should not b<s taken as an absolute' indicator of the potential for that strategy.
There have been no follow-up investigations as to Ehv this atterpt failed and b.gy to make it work.
l The federally controlled stockpiling of KI cannot ano should not be justified on risk reduction or cost / benefit considerations.
It i
l-should be viewed as being strictly defense-in-depth (as are.other i
emergency response measures) and is justified purely on prudency grounds.
NRC should actively work with the States to set up an effective system stockpiling and distributing KI.
l i
i i
-e z;+W-F 7
m er a c -
w w
+
i I
4 1
References:
1.
Memorandum dated March 26, 1997, from Peter Crane for the ACRS, transmitting Rulemaking Petition dated September 1995 on Potassium Iodide.
l l
2.
Memorandum dated February 13, 1997, from Bill M. Morris, Office of Nuclear Regulatory Research, NRC, to John T. Larkins, ACRS,
Subject:
ACRS Review of the Denial of Petition for Rulemaking i
(PRM-50-63) Relating to a Re-Evaluation of the Policy Regarding l
Use of Potassium Iodide after a Severe Accident at a Nuclear l
Power Plant.
l 1
l 1
s
.